on-invasive MRI spectroscopy at 7 Tesla in lymphoma - MRI spectroscopy in lymphoma

niversitair Medisch Centrum Utrecht0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•- Male or female patients.
•- Age: 18 years and older.
•- Under high suspicion of or histologically proven, newly diagnosed or relapsed Hodgkin lymphoma or non-Hodgkin lymphoma.
•- Patients are required to have an enlarged (i.e. diameter >= 2 cm) lymphomatous lymph node in a superficial region (e.g. head/neck, axial or inguinal in order to fit in the MRI spectroscopy field of view).
•- Patients must be capable of giving written informed consent and the consent must have been obtained before the study-related procedures.

•- General contraindications to MRI (claustrophobia, cardiac pacemakers, neurostimulators).
•- Patients with central nervous system lymphoma.
•- Previous malignancy. However, subjects who have been free of malignancy for at least 5 years, or have a history of completely resected non-melanoma skin cancer, or successfully treated in situ carcinoma are eligible.
•- Pregnant or lactating patients.

发起方

niversitair Medisch Centrum Utrecht